Trial Profile
HI 164 in smokers with COPD
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Feb 2013
Price :
$35
*
At a glance
- Drugs HI 164 (Primary)
- Indications Bacterial infections; Chronic obstructive pulmonary disease
- Focus Biomarker; Pharmacodynamics
- 20 Feb 2013 New trial record